Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000930413-06-002083
Filing Date
2006-03-15
Accepted
2006-03-15 17:13:42
Documents
17
Period of Report
2005-12-31

Document Format Files

Seq Description Document Type Size
1 c41166_10k.txt 10-K 428658
2 c41166ex_3-1.txt EX-3.1 128779
3 c41166ex_10-36.txt EX-10.36 130490
4 c41166ex_10-37.txt EX-10.37 11224
5 c41166ex_10-38.txt EX-10.38 2111
6 c41166ex_10-39.txt EX-10.39 5354
7 c41166ex_10-40.txt EX-10.40 3371
8 c41166ex_10-50.txt EX-10.50 72885
9 c41166ex_10-51.txt EX-10.51 55128
10 c41166ex_10-52.txt EX-10.52 70034
11 c41166ex_10-53.txt EX-10.53 23588
12 c41166_ex21-1.txt EX-21.1 2511
13 c41166_ex23-1.txt EX-23.1 1526
14 c41166_ex31-1.txt EX-31.1 4078
15 c41166_ex31-2.txt EX-31.2 3994
16 c41166_ex32-1.txt EX-32.1 1377
17 c41166_ex32-2.txt EX-32.2 1360
  Complete submission text file 0000930413-06-002083.txt   948166
Mailing Address 86 MORRIS AVENUE SUMMIT NJ 07901
Business Address 86 MORRIS AVENUE SUMMIT NJ 07901 (908)673-9000
CELGENE CORP /DE/ (Filer) CIK: 0000816284 (see all company filings)

EIN.: 222711928 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-16132 | Film No.: 06689045
SIC: 2834 Pharmaceutical Preparations